Cart
sales@molnova.com
Nafimidone
CAS No. 64212-22-2
Nafimidone( —— )
Catalog No. M36202 CAS No. 64212-22-2
Nafimidone shows anticonvulsant activity in a rat model of amygdala epilepsy and can be used in the treatment of chronic intractable epilepsy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 116 | Get Quote |
|
| 5MG | 168 | Get Quote |
|
| 10MG | 247 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 635 | Get Quote |
|
| 100MG | 884 | Get Quote |
|
| 500MG | 1773 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNafimidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionNafimidone shows anticonvulsant activity in a rat model of amygdala epilepsy and can be used in the treatment of chronic intractable epilepsy.
-
DescriptionNafimidone shows anticonvulsant activity in a rat model of amygdala epilepsy and can be used in the treatment of chronic intractable epilepsy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64212-22-2
-
Formula Weight236.27
-
Molecular FormulaC15H12N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CN1C=CN=C1)(=O)C2=CC3=C(C=C2)C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
STM3006
STM3006 is an orally active, selective and and potent METTL3 inhibitor with antitumor activity for the study of acute myeloid leukemia (AML).
-
Monoelaidin
Monoelaidin (1-Monoelaidin) is a compound produced by esterification of one molecule of octadecanoic acid and one molecule of glycerol.
-
DB818
DB818 is a synthetic Homeobox A9 (HOXA9) inhibitor and can be used for research on the treatment of acute myeloid leukaemia associated with HOXA9 overexpression.
